Alzamend Neuro Inc
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neur… Read more
Alzamend Neuro Inc (ALZN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2025: -0.268x
Based on the latest financial reports, Alzamend Neuro Inc (ALZN) has a cash flow conversion efficiency ratio of -0.268x as of October 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.17 Million) by net assets ($4.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Alzamend Neuro Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Alzamend Neuro Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Alzamend Neuro Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alzamend Neuro Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LETUS CAPITAL ZY 1
F:7I4
|
N/A |
|
Danel (Adir Yeoshua) Ltd
TA:DANE
|
0.035x |
|
Koncar-Elektroindustrija d.d.
ZSE:KOEI
|
N/A |
|
TMT Investments PLC
LSE:TMT
|
-0.003x |
|
Noram Lithium Corp
OTCQB:NRVTF
|
-0.046x |
|
UCAL Limited
NSE:UCAL
|
N/A |
|
Mudajaya Group Bhd
KLSE:5085
|
-0.012x |
|
The Steel Public Company Limited
BK:THE
|
0.156x |
Annual Cash Flow Conversion Efficiency for Alzamend Neuro Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Alzamend Neuro Inc from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $3.97 Million | $-6.57 Million | -1.655x | -151.92% |
| 2024-04-30 | $-2.59 Million | $-8.27 Million | 3.188x | +208.80% |
| 2023-04-30 | $3.05 Million | $-8.92 Million | -2.930x | -491.46% |
| 2022-04-30 | $13.35 Million | $-6.61 Million | -0.495x | +63.23% |
| 2021-04-30 | $2.01 Million | $-2.71 Million | -1.347x | +52.81% |
| 2020-04-30 | $821.71K | $-2.35 Million | -2.855x | +13.44% |
| 2019-04-30 | $316.92K | $-1.05 Million | -3.298x | -272.82% |
| 2018-04-30 | $2.32 Million | $-2.05 Million | -0.885x | -136.52% |
| 2017-04-30 | $-584.93K | $-1.42 Million | 2.422x | -98.61% |
| 2016-04-30 | $-106.00 | $-18.49K | 174.453x | -- |